IREB2 and cancer: Western blot analysis showed that, compared with bulk cancer cells, the protein level of IRP2 but not IRP1 was greatly reduced in esophageal CSCs (Figure1C), reflecting the iron-replete status of CSCs, which may make IRP2 protein unstable and inactivate IRP1 [18].